Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1143studies shown
Showing 565-576 of 1,143
Drug study icon
CompletedNCT02970292

Pimavanserin for schizophrenia

This study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.

In Canada
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT00439634

AVE1625 for schizophrenia

This study was terminated in the United States and in Canada. It is testing AVE1625 for schizophrenia.

In Canada
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Canada
Sponsor
Sanofi
Condition
Schizophrenia
Drug study icon
CompletedNCT01244490

Extended-release Guanfacine Hydrochloride for ADHD

This study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.

In Canada
ADHDDrugFrom 6 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Shire
Condition
ADHD
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

This study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.

In Canada
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Australia, France, Canada, ...
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01267188

NBI-98854 for adults with tardive dyskinesia

This study is completed in Canada. It focuses on adults with tardive dyskinesia.

In Canada
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Drug study icon
CompletedNCT02970305

Pimavanserin for schizophrenia

This study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.

In Canada
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00081380

Seroquel Plus Mood Stabilizer for Bipolarity

This study is completed in the United States and in Canada. It is testing seroquel Plus Mood Stabilizer for Bipolarity.

In Canada
BipolarityDrugOver 18 Years
Countries
United States, Canada
Sponsor
AstraZeneca
Condition
Bipolarity
Behavioral study icon
CompletedNCT03711019

Efficacy of Convulsive Therapies During Continuation

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
Depression, BipolarityBehavioralOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.